Cited by 235Bone health and osteoporosis researchHormonal and reproductive studiesBone Metabolism and Diseases

Longitudinal Association between Sex Hormone Levels, Bone Loss, and Bone Turnover in Elderly Men

Gennari, Luigi, Merlotti, Daniela, Martini, Giuseppe, Gonnelli, Stefano, Franci, Beatrice, Campagna, Stella, Lucani, Barbara, Dal Canto, Norberto +3 more·2003·The Journal of Clinical Endocrinology & Metabolism

Abstract

Male osteoporosis is an increasingly important health problem. It is known that sex steroid hormones play an important role in regulating bone turnover and bone mass in males as well as in females. However, the exact mechanism of bone loss in men remains unknown. In the present study, 200 elderly men (age range, 55–85 yr) were followed for 4 yr to evaluate the relationships between hormone levels, bone turnover markers, bone mineral density, and rates of bone loss. Femoral and lumbar bone mineral density, bone ultrasound parameters at the os calcis, serum testosterone (T), serum estradiol (E2), SHBG levels, and bone turnover markers (urinary crosslaps and bone alkaline phosphatase) were evaluated for each man at enrollment and 4 yr afterward. The free androgen index (FAI) and free estrogen index (FEI) as well as measures of the bioavailable sex hormones [calculated bioavailable E2 (c-bioE2) and T (c-bioT)] were calculated from total hormone levels and SHBG. In the total population, T, c-bioT, c-bioE2, FAI, and FEI, but not E2, decreased significantly with age, whereas SHBG increased significantly. Subjects with FEI, c-bioE2, and E2 levels below the median showed higher rates of bone loss at the lumbar spine and the femoral neck as well as higher speed-of-sounds decrease at the calcaneus with respect to men with FEI, c-bioE2, and E2 levels above the median. Serum bone alkaline phosphatase and urinary crosslaps were significantly higher in men with FEI, c-bioE2, and E2 in the lower quartile than in men with FEI, c-bioE2, and E2 levels in the higher quartile. No statistically significant differences were observed in relation to T, c-bioT, or FAI levels. Finally, the ratio between E2 and T, an indirect measure for aromatase activity, increased significantly with age and was higher in normal than in osteoporotic subjects. In conclusion, results from the present study indicate an important role of estrogens, and particularly of the ability to aromatize T to E2, in the regulation of bone loss and bone metabolism in elderly men.

Integrity signals

Registry

Crossref · 10.1210/jc.2003-030736

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GH-deficient boys treated with GH and anastrozole showed a larger increase in height than their GH only-treated controls.

    “As expected, GH-deficient boys treated with GH and anastrozole showed a larger increase in height than their GH only-treated controls [63].”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [63]

The citation lists haven’t been fetched yet

References 43 · Cited by 235

Authors
Gennari, L., Merlotti, D., Martini, G., Gonnelli, S., Franci, B., Campagna, S., Lucani, B., Dal Canto, N., Valenti, R., Gennari, C., & Nuti, R.
Affiliations
  • University of Siena (IT)
  • Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, 53100 Siena, Italy
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-11-01
Volume
88
Issue
11
Pages
5327-5333
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2122147292
Cited by
235
References
43
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 10 · 2017: 6 · 2016: 6 · 2015: 11 · 2014: 15 · 2013: 9 · 2012: 12
FWCI
15.32
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Use Siena air (University of Siena) (submittedVersion)
Funders
  • Università degli Studi di Siena
  • International Osteoporosis Foundation
  • Servier
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
male osteoporosis, sex hormones, bone loss, bone turnover markers, testosterone, estradiol, sex hormone-binding globulin, free androgen index, aromatase activity, bone mineral density, bone ultrasound, older men, bone metabolism
MeSH terms
Aged, Bone Resorption, Estradiol, Femur Neck, Humans, Longitudinal Studies, Lumbar Vertebrae, Male, Middle Aged, Osteoporosis, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Testosterone, Bone Density, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review